Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

  1. Philip, P.A.
  2. Lacy, J.
  3. Portales, F.
  4. Sobrero, A.
  5. Pazo-Cid, R.
  6. Manzano Mozo, J.L.
  7. Kim, E.J.
  8. Dowden, S.
  9. Zakari, A.
  10. Borg, C.
  11. Terrebonne, E.
  12. Rivera, F.
  13. Sastre, J.
  14. Bathini, V.
  15. López-Trabada, D.
  16. Asselah, J.
  17. Saif, M.W.
  18. Shiansong Li, J.
  19. Ong, T.J.
  20. Nydam, T.
  21. Hammel, P.
Aldizkaria:
The Lancet Gastroenterology and Hepatology

ISSN: 2468-1253

Argitalpen urtea: 2020

Alea: 5

Zenbakia: 3

Orrialdeak: 285-294

Mota: Artikulua

DOI: 10.1016/S2468-1253(19)30327-9 GOOGLE SCHOLAR